Survival Analysis of Cancer Patients of Differing Payer Type in South West Virginia, Between 2000 and 2013.

Autor:	Annie FH; Cardiology, Charleston Area Medical Center/Health Education and Research Institute, Charleston, USA., Uejio CK; Geography, Florida State Universiy, Charleston , USA., Bhagat A; Internal Medicne, Charleston Area Medical Center, Charleston, USA., Kochar T; Internal Medicine, West Virginia University/Charleston Area Medical Center, Charleston, USA., Embrey S; University of Charleston, School of Pharmacy, Charleston, USA., Tager A; Emergence Medicine, Charleston Area Medical Center, Charleston, USA.
Jazyk:	angličtina
Zdroj:	Cureus [Cureus] 2018 Jul 22; Vol. 10 (7), pp. e3022. Date of Electronic Publication: 2018 Jul 22.
DOI:	10.7759/cureus.3022
Abstrakt:	Introduction The effect of insurance coverage on the health of at-risk populations is poorly understood in the Appalachian region of the United States. The goal of this study is to examine how different types of insurance coverage (Private Insurance, Medicare under 65, Medicare 65 or over, Medicaid and Self Pay) may influence cancer survival over time. This study analyzes colon, bladder, as well as combines anal, rectal, and esophageal cancers. Methods We systematically analyzed all West Virginia Cancer Registry patients between the years of 2000 and 2013 who was diagnosed with colon, bladder, anal, rectal, and esophageal cancers. Separate analysis examined colon (n = 927), bladder (n = 269), and combined anal, rectum, and esophageal cancers (n = 398). Cox proportional hazards models investigated the effect of insurance types on survival while controlling for age, sex, tobacco use, alcohol use, and cancer stage. Results Overall, tobacco use marginally significantly decreased colon cancer survival. Tobacco use had a suggestive relationship at hazards ratio at 1.150, 95% confidence interval: 0.9990-1.235, p = 0.052. The type of payer group did not alter survival. Older individuals tend to have a lower survival rate compared to those that are younger at the time of diagnosis. Also, late-stage cancer faced lower survival compared to those with early-stage cancer. Other results within stage groups corresponded to existing literature. Conclusion For the three differing cancer groupings, there was no significant survival difference for patients by insurance type. The effect of tobacco usage on colon cancer survival merits further research. The study design could be improved by considering more risk factors such as patient comorbidities that might affect patient care and survival. Competing Interests: The authors have declared that no competing interests exist.
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu